Insider Transactions in Q4 2023 at Teladoc Health, Inc. (TDOC)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 26
2023
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
27,310
-76.01%
|
$600,820
$22.0 P/Share
|
|
Dec 20
2023
|
Karen L Daniel Director |
SELL
Open market or private sale
|
Direct |
14,073
-27.56%
|
$295,533
$21.41 P/Share
|
|
Dec 18
2023
|
Daniel Trencher CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
1,000
-5.05%
|
$20,000
$20.36 P/Share
|
|
Dec 04
2023
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
SELL
Open market or private sale
|
Direct |
397
-1.52%
|
$7,146
$18.9 P/Share
|
|
Dec 04
2023
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
410
-1.42%
|
$7,380
$18.9 P/Share
|
|
Dec 04
2023
|
Jason N Gorevic CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
2,877
-0.48%
|
$51,786
$18.9 P/Share
|
|
Dec 04
2023
|
Nikolaos P. Nanis Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
508
-0.78%
|
$9,144
$18.9 P/Share
|
|
Dec 04
2023
|
Daniel Trencher CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
427
-2.11%
|
$7,686
$18.9 P/Share
|
|
Dec 04
2023
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
SELL
Open market or private sale
|
Direct |
965
-3.95%
|
$17,370
$18.9 P/Share
|
|
Dec 04
2023
|
Stephany Verstraete CHIEF MARKETING OFFICER |
SELL
Open market or private sale
|
Direct |
509
-1.17%
|
$9,162
$18.9 P/Share
|
|
Dec 04
2023
|
Mala Murthy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,004
-5.74%
|
$54,072
$18.9 P/Share
|
|
Dec 04
2023
|
Richard J Napolitano CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
652
-5.79%
|
$11,736
$18.9 P/Share
|
|
Dec 01
2023
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
BUY
Exercise of conversion of derivative security
|
Direct |
1,347
+4.91%
|
-
|
|
Dec 01
2023
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,179
+3.93%
|
-
|
|
Dec 01
2023
|
Jason N Gorevic CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,615
+0.92%
|
-
|
|
Dec 01
2023
|
Nikolaos P. Nanis Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,399
+1.07%
|
-
|
|
Dec 01
2023
|
Daniel Trencher CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,179
+5.51%
|
-
|
|
Dec 01
2023
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
1,881
+7.15%
|
-
|
|
Dec 01
2023
|
Stephany Verstraete CHIEF MARKETING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,404
+3.12%
|
-
|
|
Dec 01
2023
|
Mala Murthy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,412
+5.02%
|
-
|
|
Dec 01
2023
|
Claus Torp Jensen CHIEF INNOVATION OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,850
+11.03%
|
-
|
|
Dec 01
2023
|
Richard J Napolitano CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,796
+5.29%
|
-
|
|
Nov 27
2023
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
346
-1.24%
|
$5,882
$17.04 P/Share
|
|
Nov 17
2023
|
Sandra L Fenwick Director |
BUY
Exercise of conversion of derivative security
|
Direct |
436
+3.49%
|
-
|
|
Nov 17
2023
|
Daniel Trencher CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
1,000
-4.99%
|
$17,000
$17.07 P/Share
|
|
Nov 17
2023
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
SELL
Bona fide gift
|
Direct |
49,096
-63.68%
|
-
|
|
Nov 17
2023
|
Karen L Daniel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
436
+0.85%
|
-
|
|
Nov 02
2023
|
Michael Willem Waters CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
5,482
-14.71%
|
$93,194
$17.05 P/Share
|
|
Nov 02
2023
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,962
-12.13%
|
$84,354
$17.05 P/Share
|
|
Nov 02
2023
|
Laizer Kornwasser Advisor to the CEO |
SELL
Open market or private sale
|
Direct |
35,887
-44.42%
|
$610,079
$17.05 P/Share
|
|
Nov 01
2023
|
Michael Willem Waters CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
11,319
+23.3%
|
-
|
|
Nov 01
2023
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,244
+20.03%
|
-
|
|
Nov 01
2023
|
Laizer Kornwasser Advisor to the CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
80,794
+50.0%
|
-
|
|
Oct 31
2023
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
365
-0.47%
|
$5,840
$16.28 P/Share
|
|
Oct 30
2023
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,061
+1.35%
|
-
|
|
Oct 17
2023
|
Daniel Trencher CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
1,000
-4.75%
|
$18,000
$18.74 P/Share
|